Pharma and healthcare: sector news on Wednesday 11 November 2026
Average tone +0.8 (neutral) across 4 companies with relevant coverage, from 32 stories.
How to read a score. Each score rates how good or bad the news was for the company, from −10 (clearly bad) to +10 (clearly good). 0 is neutral, and anything beyond ±6 is strong and rare. It rates the coverage, not the share price.
Company by company
| Company | Tone | Stories | What the coverage was about |
|---|---|---|---|
| AstraZeneca | +6.3 | 22 | Coverage was dominated by the acquisition of vaccine start-up Omniose, which adds a bioconjugation platform to the vaccine pipeline. |
| GSK | +4.5 | 6 | |
| Haleon | −6.3 | 3 | Coverage centred on slower third-quarter growth, a tighter outlook and a guidance cut, which led to a lower fair value estimate and mixed analyst revisions. |
| Convatec | −1.3 | 1 | Coverage focused on a change of finance chief at Convatec and whether it alters the investment case. |
| Smith & Nephew | — | 0 |
Strongest stories in the sector
- +9.2 High placing in access-to-medicine ranking boosts reputation.
- +8.3 European approval widens use of a key cancer drug.
- −8.3 Lower valuation estimate after reduced guidance and split analyst changes.
- +7.5 Regulatory approval for cancer drug refocuses attention on valuation.
- +7.0 Acquisition of US biotech adds to its vaccine pipeline.
- +7.0 Deal advances its bacterial vaccine research.
- +6.7 Buying existing partner secures bacterial vaccine technology.
- +6.7 Takeover adds a bioconjugation technology to vaccine research.
- +6.7 Acquisition of vaccine startup expands its vaccine capabilities.
- +6.7 Deal brings a bioconjugate vaccine technology platform in-house.
- +6.7 Purchase of a St. Louis vaccine developer strengthens its portfolio.
- +6.3 Target company confirms being bought by AstraZeneca.
Pharma and healthcare: every day · FTSE 100 overview for the day
Follow by email
A short, free morning email on how the news treated the Pharma and healthcare sector: the tone, the stories behind it, and when coverage starts to turn. Launching soon; one click to unsubscribe.